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Background: The purpose of this study is to investigate the feasibility, accuracy, and limitations of ultrasound
(US)-guided core needle biopsy (CNB) with multiple punches in the diagnosis of lymphoma in the whole body.
Methods: From March 2007 to October 2013, US-guided CNB with multiple punches was performed by
well-experienced radiologists in 110 patients (CNB group), and surgical biopsy was carried out in 95 patients
(surgical group). The differences of accuracy rate between the two groups in the diagnosis of lymphoma and
its subtypes were examined with Fisher’s exact test.
Results: There were no statistical differences between the CNB group and the surgical group in the diagnostic
accuracy rate of lymphoma, as well as its subtypes in superficial and deep masses. In addition, in the CNB group, there
were no statistical differences between different lengths of lesions in the diagnosis accuracy rate of lymphoma and
its subtypes.
Conclusions: US-guided CNB with no less than three punches is an accurate, safe, minimally invasive, non-radiological,
fast, and cost-effective method in the evaluation of lymphoma and its subtypes as compared with surgical approach.
It should be considered as the acceptable alternative to surgical biopsy to obtain histopathological samples in the
patients with suspected lymphoma.
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Different subtypes of lymphoma vary in clinical manifes-
tations, treatment, and prognosis; therefore, early diag-
nosis and histological classification are crucial for the
assignment of therapeutic schedule [1]. In the past, con-
firmed diagnosis and classification of lymphoma mainly
relied on surgical biopsy which not only increased the pa-
tients’ pains but also added up to their medical costs [2].
In recent years, minimally invasive techniques are grad-
ually gaining recognition and have been widely used in the
diagnoses of lymphoma.
Among the minimally invasive techniques, core needle
biopsy (CNB) has been recognized as an alternative
technique for diagnosing and subclassing the malignant* Correspondence: hebosheng@126.com
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unless otherwise stated.lymphomas. This technique not only provides the archi-
tecture of the lymph node and sufficient tissue for further
examinations such as immune phenotype, molecular gen-
etics, and molecular biology as compared with fine needle
biopsy (FNB) but also saves more than 75% of costs as
compared with surgical biopsy [3]. Moreover, CNB is a
non-radiological and real-time examination and may be
the first initial approach chosen for people who cannot
endure surgery, especially for feeble or older people.
Therefore, CNB has gradually been accepted as an alterna-
tive method in the diagnosis of patients with lymphoma in
the United States and some Western European countries
because of its good applicability, safety, and high diagnos-
tic rate [4-11].
It has been well established that CNB is effective and
useful in the diagnosis of malignant lymphomas in many
organs, such as head, neck, breast, thyroid, chest, and
abdomen [11-17]. However, some studies merely focusedis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Bard Magnum tissue-cutting needle and the third
generation automatic biopsy gun (big arrow); tissue strips
obtained with CNB (small arrow).
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or merely paid close attention to one or two organs. In
addition, the influence on different lengths of lesions in
the diagnosis accuracy of lymphoma and its subtypes by
means of CNB is still not clear.
The purpose of this study was to investigate the feasibil-
ity, accuracy, and limitations of ultrasound (US)-guided
CNB with multiple punches in the diagnosis of lymphoma
in the whole body and evaluate its clinical value. The
differences between CNB and surgical group in the diag-
nostic accuracy rate of lymphoma and its subtypes in
superficial and deep masses of the whole body were com-
pared, as well as the influence on different lengths of
lesions in the diagnosis accuracy rate of lymphoma and
its subtypes in CNB group.
Methods
Patients
A total of 205 patients underwent biopsy in the Depart-
ment of Ultrasound, The Cancer Hospital of Nantong
University for lymphoma lesion biopsy between March
2007 and October 2013 were enrolled. All patients were
randomly assigned to US-guided CNB group and sur-
gery group. All biopsies were done on an outpatient
basis, unless inpatient medical supervision is needed. In
the US-guided CNB group, there were 110 patients
(aged 58.4 ± 17.3 years) consisting 60 males and 50
females. There were 62 cases of superficial masses (neck,
axillary, groin, breast, vertical muscle, back) and 48 cases
of deep masses (abdominal cavity, retroperitoneum). A
total of 95 patients consisting 56 males and 39 females
were assigned to the surgery group. The mean age was
58.9 ± 14.4 years. Surgery biopsies included 60 cases of
superficial masses (neck, axillary, groin, breast, vertical
muscle, back) and 35 cases of deep masses (abdominal
cavity, retroperitoneum). However, two patients failed to
be defined as subtypes of lymphoma after the first surgi-
cal biopsy. Six months later, they were confirmed as
lymphoma and its subtypes in the second surgical
biopsy.
Informed consents were obtained from all participants
before CNB or surgery. Additionally, this study was ap-
proved by the Cancer Hospital of Nantong University
medical ethics committees.
Ultrasound-guided CNB
All biopsies were conducted under the supervision of
color doppler ultrasonography (Philips IU-22, Amsterdam,
The Netherlands) with probe frequencies of 2 to 5 MHz
(low frequency) and 5 to 12 MHz (high frequency). The
14-gauge (14G) and 16-gauge (16G) cutting needles and
the third generation automatic biopsy gun (Bard Magnum,
Covington, GA, USA) (Figure 1) were used to the biopsies.
The length of needle groove was 15 or 22 mm, dependingupon the size of nodal and proximity of vessels [18]. The
high-frequency probe-guided 14G core needle and low-
frequency probe-guided 16G core needle were used to
the biopsies of superficial and deep masses, respect-
ively (Figure 2).
Normal coagulation screening tests, including pro-
thrombin time (PT), platelet count, and partial thrombo-
plastin time (PTT), were performed before biopsy [19].
If the results were confirmed to be normal, CNB would
be performed to the patients. The routine US was car-
ried out to investigate the shape, echo, size, and blood
supply of the masses, and the relationships among the
masses, surrounding organs, and great vessels, besides
the medium length of the lesions, were recorded and
compared between the two groups. All the biopsies were
performed by well-experienced radiologists. The local
anesthesia was administered using 2% lidocaine. Under
the real-time supervision of US, the needle was inserted
at the edge of the mass and the biopsy gun was instant-
aneously excited to collect at least three times in differ-
ent parts of the mass (one needle in the center and two
needles at the periphery of the mass). Intact tissue strips
with a length of more than 0.5 cm were considered to be
satisfactory samples.
Different body positions were chosen according to dif-
ferent sites of the masses and the locations of samples.
The sampling was collected with the help of surgical knife
blade, especially for the tough skin. Moreover, the sampling
points should be as close as possible to the body surface
and avoid the necrotic areas. The samples should be har-
vested from hyper-vascular tissue (Figure 3). After CNB,
Figure 2 Ultrasonograms of the needle tracts. (a) The ultrasonogram of the needle tract in the superficial masses after ejection of biopsy gun
(arrow); (b) the ultrasonogram of the needle tract in the deep masses after ejection of biopsy gun (arrow).
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avoid subcutaneous hematoma.
Surgical biopsy
Adequate preoperative evaluation was done to master
the indications, and normal coagulation screening tests
were also assigned to the patients prior to the operation.
If the results were confirmed to be normal, surgery
would be allowed to perform. The surgical approach and
biopsy range of masses were determined after a compre-
hensive analysis of clinical and imaging materials. All the
surgical operation was performed by well-experienced sur-
geons. Excisional biopsy tissue should include the outer
edge of the masses and hyper-vascular areas. The mass
which was less than 3 cm should be wholly excised.
After the surgical biopsy, all patients in these two groups
were kept under observation and then were returned toFigure 3 CDFI shows the rich blood flow in the lesion (arrow).wards only if there was no sign or symptom of complica-
tions, such as bleeding. All patients were encouraged to
call a doctor if they felt uncomfortable.
Pathological diagnosis of lymphoma
After excision of the lesions, the final diagnosis for each
case was established by secondary histopathology exam-
ination which was considered as a gold standard. All
samples were placed in 10% formalin and embedded in
paraffin. Serial sections (4 μm) were cut and stained with
hematoxylin and eosin (HE). However, histologic exam-
ination which is utilized to reveal the morphology of
lymphomas is now not adequate to distinguish the differ-
ent categories of lymphoma. Molecular pathology tech-
niques, such as immunohistochemistry (IHC), have been
proven effective in diagnostic approaches to malignant
lymphoma. Immunophenotyping to determine lineage
and clonality using more than 80 different monoclonal
antibodies is now supported to distinguish the different
categories of lymphoma. Hence, IHC was performed to
assess the immunophenotyping in our study. The appro-
priate selection of the specific monoclonal antibodies
should be based on morphology and relevant clinical data
to avoid pitfalls in the interpretation of IHC data. In our
study, IHC was implemented using EnVision two-step
method on a panel of antibodies [20]: leukocyte common
antigen (LCA), cluster designation (CD)20, CD79a, CD10,
Bcl-6, multiple myeloma oncogene (MUM)1, Ki-67, Bcl-2,
Bcl-10, CD5, CyclinD1, CD23, anaplastic lymphoma kin-
ase (ALK)-1, CD3, CD45RO, CD56, TIA-1, and CXCL13
(Beijing Zhongshan Jinqiao Biotechnology Corporation
Limited). Pathological diagnosis was referred to WHO
classification of lymphatic and hematopoietic tumors.
Statistical analysis
Continuous variables were expressed as the mean ±
standard deviation (SD). Statistical analysis was performed
with the STATA10.0 statistical software package (STATA
Corporation, College Station, TX, USA). The accuracy rate
Table 2 Number of punctures in CNB group








CNB, core needle biopsy.








NHL 108 (98.2%) 94 (98.9%)
Diffuse large B cell lymphoma 85 (78.7%) 63 (67.0%)
Anaplastic large cell lymphoma 7 (6.5%) 3 (3.2%)
Mantle cell lymphoma 3 (2.8%) 8 (8.5%)
Follicular lymphoma 2 (1.9%) 5 (5.3%)
Small B cell lymphomas 2 (1.9%) 0 (0%)
Small lymphocytic lymphoma/leukemia 2 (1.9%) 1 (1.1%)
Nodal marginal zone B cell lymphoma 1 (0.9%) 1 (1.1%)
Lymphoblastic leukemia, T cell 1 (0.9%) 0 (0%)
Unspecified peripheral T cell lymphoma 1 (0.9%) 2 (2.1%)
Angioimmunoblastic T cell lymphoma 1 (0.9%) 0 (0%)
Burkitt’s lymphoma 1 (0.9%) 0 (0%)
B lymphocytic lymphoma/leukemia 1 (0.9%) 3 (3.2%)
Plasma cell differentiation large B cell
lymphoma
1 (0.9%) 0 (0%)
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0.05 were considered to be statistically different.
Results and discussion
CNB group
The medium length of the lesions was 7.3 cm (range 2.3
to 12.3 cm). Majority of the lesions were greater than
3 cm (84.5%, 93/110) (Table 1). During the puncture,
three patients presented pains and one patient appeared
minor hemorrhage (<60 ml). There was no serious compli-
cation in all cases. The medium length of tissue strips of
each case was 1.5 cm (range 1.2 to 1.8 cm). The medium
puncture number was 3.1 needles (range 2 to 6 needles)
(Table 2). One patient was punctured for two needles due
to local bleeding. The final pathological diagnosis included
2 cases of Hodgkin lymphoma (HL) and 108 cases of non-
Hodgkin lymphoma (NHL) (Table 3). Diffuse large B cell
lymphoma accounted for 77.3% (85/110). Eight patients
failed to be defined as subtypes of lymphoma after the first
CNB (including five patients undiagnosed as lymphoma).
All the eight cases were assigned to further surgical biopsy
to confirm the diagnosis (one case was performed two
times) (Table 4).
Surgical group
During the procedure, there were 5 patients who had
hemorrhage (100 to 200 ml) and 10 patients presented
incision pain. The final pathological diagnosis included 1
case of HL and 94 cases of NHL (Table 3). Two cases
failed to be diagnosed as lymphoma and its subtypes in
the first surgical biopsy. They were confirmed to be fol-
licular lymphoma and diffuse large B cell lymphoma after
the secondary surgical biopsy. Among the 95 cases, one
patient with retroperitoneal tumor presented hypoprotei-
nemia a week after the surgical biopsy but was improved
after symptomatic treatment. The surgical incision healed
slowly in one patient who had diabetes. There were no
serious complications in all cases.
Comparison of diagnosis accuracy rate between the two
groups
There was no statistical difference between CNB and
surgical group in the diagnostic accuracy rate of lymph-
oma and its subtypes in superficial (P = 0.68; P = 0.273)








D ≤ 3 17 88.2 (15/17) 82.3 (14/17)
3 < D≤ 5 34 97.1 (33/34) 94.1 (32/34)
D > 5 59 96.6 (57/59) 95.0 (56/59)
CNB, core needle biopsy; D, the length of llesions.In the CNB group, there was no statistical difference be-
tween different lengths of masses in the diagnostic ac-
curacy rate of lymphoma and its subtypes.
Discussion
In our present study, we investigated the feasibility, ac-
curacy, and limitations of CNB with multiple punches in
the diagnosis of lymphoma in the whole body. The re-
sults suggested that US-guided CNB with no less than
three punches was an accurate, safe, minimally invasive,
non-radiological, fast, and cost-effective method in theB cell lymphoma of mucosa-associated
lymphoid tissue
0 (0%) 5 (5.3%)
T-lymphoblastic lymphoma 0 (0%) 2 (2.1%)
NK/T cell lymphoma 0 (0%) 1 (1.1%)
HL 2 (1.8%) 1 (1.1%)
Hodgkin lymphoma nodular sclerosing type 2 (100%) 0 (0%)
Hodgkin lymphoma mixed cellularity type 0 (0%) 1 (100%)
CNB, core needle biopsy.
Table 4 Eight cases undiagnosed as subtypes of lymphoma with CNB
Location Pathological diagnosis with CNB Pathological diagnosis with surgical biopsy Remarks
Abdominal cavity Malignant tumor, poorly differentiated carcinoma Diffuse large B cell lymphoma 5 years after gastric
cancer operation
Abdominal cavity Lymphoma Diffuse large B cell lymphoma
Left inguinal region Lymphadenosis Small lymphocytic lymphoma/leukemia Hemorrhage
Right neck Lymphadenosis heteromorphosis Anaplastic large cell lymphoma It is confirmed after
the second surgery
Left armpit Lymphadenosis heteromorphosis Small B cell lymphomas
Right armpit Chronic inflammation accompanied with lymphadenosis Angioimmunoblastic T cell lymphoma
Left armpit Lymphoma Unspecified peripheral T cell lymphoma
Right neck Lymphoma Nodal marginal zone B cell lymphoma Rare type
CNB, core needle biopsy.
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surgical approach.
US-guided CNB is a non-radiological and real-time
examination, which can provide blood flow information
of lesions ensuring the accuracy of sampling. Moreover,
the obtained sample is intact, and the cells are not com-
pressed which is helpful for pathological examination
[21]. In addition, CNB enables us to streamline patient
care and reduce operating time and expense compared
with surgery [21]. Previous study indicated that the suc-
cess rate of CNB was significantly higher than FNB
(37.6%) [22] and CT-guided CNB (71.5%) [23]. A large
number of studies have documented that CNB is an ef-
fective and reliable procedure with a high diagnostic
yield for lymphoma [9,24,25].In our studies, we evalu-
ated the diagnostic accuracy of lymphoma and its sub-
types in superficial and deep masses using CNB and
surgery. The results showed that there was no statistical
difference (P = 0.273, and P = 0.506, respectively), indi-
cating that CNB was not only suited for deep masses but
also for superficial masses. In the past, surgery was advo-
cated for superficial masses; however, our study provided
some evidence to back up CNB for diagnosing superfi-
cial masses. What is more, we also found that there was
no significant difference between different lengths ofTable 5 Diagnostic accuracy of lymphoma and its
subtypes between CNB and surgical group in superficial
and deep masses
Location Diagnosis CNB group Surgical group P
Superficial masses Lymphoma 93.5 (58/62) 96.6 (58/60) 0.68
Subtypes 90.3 (56/62) 96.6 (58/60) 0.273
Deep masses Lymphoma 97.9 (47/48) 100 (35/35) 1
Subtypes 95.8 (46/48) 100 (35/35) 0.506
Total Lymphoma 95.4 (105/110) 97.9 (96/98) 0.454
Subtypes 92.7 (102/110) 97.9 (96/98) 0.11
CNB, core needle biopsy.lesions in the diagnostic accuracy rate of lymphoma and
its subtypes.
Hemorrhage is the most common complication of nee-
dle biopsy, and the incidence is 0.8% to 3.0% [26,27]. In
our study, there was only one patient who had minor
hemorrhage (<60 ml) and three patients presented pains.
In addition, there were no serious complications in all
cases. Whereas, there were 5 patients who had hemorrhage
(100 to 200 ml) and 10 patients presented incision pain in
the surgery group. On the whole, the US-guided CNB re-
duced the complications as compared with surgical biopsy.
Although percutaneous US-guided CNB is currently
the best way to obtain positive histopathological diagno-
sis of lymphoma under the non-surgical conditions, sev-
eral points should be noted. First of all, CNB should be
performed by well-experienced radiologists to acquire
adequate sample. Secondly, sufficient and high-quality
sample volume may be the key factors affecting the ac-
curacy rate of CNB [28,29]. Therefore, sampling sites
should be chosen in or closed to the rich blood supply
areas and in the periphery of the lesion. Thirdly, US-
guided CNB should be used for the lesions visualized
clearly by ultrasound; however, for the lesions which
could not be displayed clearly by US or negative results
of CNB, local surgical biopsy should be performed.
Fourthly, the application of 14G and 16G needles and
automatic biopsy gun also should be noteworthy. In our
study, 14G and 16G were used to the biopsies of superfi-
cial and deep masses, respectively. The choice of biopsy
needle size mainly depends on the size and localization
of lesions [14]. Generally speaking, large core needles
(usually 14G) are utilized to superficial biopsies, whereas
smaller needles (18 or 16G) are performed on deep bi-
opsies [30]. The last point is multi-point sampling. Usu-
ally, lymphoma is characterized by multifocal in origin;
therefore, multi-point sampling should be conducted to
acquire effective and adequate tissue. Bolivar et al. [31]
suggested that each lesion should be punctured for no
less than three needles in the diagnostic value of US-
He et al. World Journal of Surgical Oncology  (2015) 13:126 Page 6 of 7guided 14G CNB in non-palpable suspicious breast
lesions. In line with their study, we also found that no
less than three punches may be effective for CNB in
diagnosing lymphoma in our study.
In the CNB group, eight patients failed to be defined
as subtypes of lymphoma after the first CNB (including
five patients undiagnosed as lymphoma). The eight pa-
tients then underwent surgical biopsy to confirm the final
diagnosis and subtypes of lymphoma. Of the five patients
undiagnosed as lymphoma, one patient was confirmed
finally to have anaplastic large cell lymphoma. The reasons
for the failure of diagnosis with CNB may be relevant to
reactive hyperplasia in the sampling areas or the sample
was not a representative of the characteristics of lymph-
oma. One patient had minor hemorrhage and was punc-
tured with only two needles resulting in the reduction of
sample volume. For the other one case, the tumor was
the largest among all patients enrolled in this study and
the sample was probably punctured in necrotic tissues. In
the three cases failed to be confirmed to be subtypes of
lymphoma, one case was a rare type (nodal marginal zone
B cell lymphoma) and the diagnosis may be difficult,
and the other two cases may be relevant to less sample
volume.
However, there were several limitations in our study.
The lesions were only divided into superficial and deep
masses; the specific location of the enlarged lymph nodes
was not taken into consideration. The lesions which were
not displayed clearly by US were not enrolled in the
CNB group. All of these may lead to biased results.
In addition, our study did not intensively investigate the
quality control factors of the golden standard (pathological
diagnosis).
Conclusions
In summary, US-guided CNB with no less than three
punches is an accurate, safe, minimally invasive, conveni-
ent, fast, and low-cost method in the evaluation of lymph-
oma and its subtypes. It should be used as the acceptable
alternative to surgical biopsy to obtain histopathological
samples in the patients with suspected lymphoma.
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